World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
28820
World Ranking
1112
National Ranking
593

Medicine

D-Index
89
Citations
28897
World Ranking
12694
National Ranking
6489

Sina Bavari publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sina Bavari sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 378 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sina Bavari D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sina Bavari sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sina Bavari is affiliated with the United States Army Medical Research Institute of Infectious Diseases in the United States. Their research primarily focuses on the field of Medicine, with a specialization in Infectious Diseases. Additional subfields include Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, and Virology.

The main topics covered in Sina Bavari's research encompass:

  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 and COVID-19 Research
  • Mosquito-borne diseases and control
  • Poxvirus research and outbreaks
  • Hepatitis B Virus Studies
  • Disaster Response and Management

The scientist has contributed to several recent papers, including:

  • 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales, 2020, Archives of Virology
  • 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales, 2021, Archives of Virology
  • Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus, 2020, The Journal of Infectious Diseases
  • The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines, 2020, Virus Research
  • Inactivated COVID-19 vaccines to make a global impact, 2021, The Lancet Infectious Diseases

Frequent co-authors in their publications include:

  • Farooq Nasar
  • Seth Lederman
  • Patrick L. Iversen
  • Jesse Steffens
  • Franco Rossi

The scientist's work has appeared in various publication venues, with the most frequent being:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Archives of Virology
  • The Lancet Infectious Diseases
  • Viruses
  • PLoS neglected tropical diseases

Best Publications

  • Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

    Travis K. Warren;Robert Jordan;Michael K. Lo;Adrian S. Ray

  • Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

    Yumiko Imai;Keiji Kuba;Keiji Kuba;G. Greg Neely;Rubina Yaghubian-Malhami

  • Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

    Dustin Siegel;Hon C. Hui;Edward Doerffler;Michael O. Clarke

  • Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

    Travis K. Warren;Jay Wells;Rekha G. Panchal;Kelly S. Stuthman

  • Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

    I-Chueh Huang;Charles C. Bailey;Jessica L. Weyer;Sheli R. Radoshitzky

  • Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

    Mansour Mohamadzadeh;Scott Olson;Warren V. Kalina;Gordon Ruthel

  • Lipid Raft Microdomains A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses

    Sina Bavari;Catharine M. Bosio;Elizabeth Wiegand;Gordon Ruthel

  • Taxonomy of the order Mononegavirales: update 2016

    Claudio L. Afonso;Gaya K. Amarasinghe;Krisztián Bányai;Yīmíng Bào

  • Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose

    Jasdave S. Chahal;Omar F. Khan;Christopher L. Cooper;Justine S. McPartlan

  • Reemergence of Monkeypox: Prevalence, Diagnostics, and Countermeasures

    Robert A. Weinstein;Aysegul Nalca;Anne W. Rimoin;Sina Bavari

  • Taxonomy of the order Mononegavirales: update 2018

    Gaya K. Amarasinghe;Nidia G. Aréchiga Ceballos;Ashley C. Banyard;Christopher F. Basler

  • Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation

    Catharine M. Bosio;M. Javad Aman;Case Grogan;Robert Hogan

  • Taxonomy of the order Mononegavirales: update 2019.

    Gaya K. Amarasinghe;María A. Ayllón;Yīmíng Bào;Christopher F. Basler

  • Ebola Virus-Like Particle-Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge

    Kelly L. Warfield;Dana L. Swenson;Gene G. Olinger;Warren V. Kalina

  • Ebola virus-like particles protect from lethal Ebola virus infection

    Kelly L. Warfield;Catharine M. Bosio;Brent C. Welcher;Emily M. Deal

  • Taxonomy of the order Mononegavirales: update 2017

    Gaya K. Amarasinghe;Yīmíng Bào;Christopher F. Basler;Sina Bavari

  • A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

    Peter B. Madrid;Sidharth Chopra;Ian D. Manger;Lynne Gilfillan

  • 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

    Jens H. Kuhn;Scott Adkins;Daniela Alioto;Sergey V. Alkhovsky

  • Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

    Peter B Madrid;Rekha G Panchal;Travis K Warren;Amy C Shurtleff

  • Vaccine adjuvant uses of poly-IC and derivatives

    Karen A O Martins;Sina Bavari;Andres M Salazar

  • Advanced antisense therapies for postexposure protection against lethal filovirus infections

    Travis K Warren;Kelly L Warfield;Jay Wells;Dana L Swenson

  • Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and

    Marburg Viruses;Sina Bavari;Catharine M. Bosio;Elizabeth Wiegand

Frequent Co-Authors

Kelly L. Warfield
Kelly L. Warfield United States Department of the Army
Jens H. Kuhn
Jens H. Kuhn National Institutes of Health
Sheli R. Radoshitzky
Sheli R. Radoshitzky Center for Drug Evaluation and Research
M. Javad Aman
M. Javad Aman Integrated BioTherapeutics (United States)
Gustavo Palacios
Gustavo Palacios Icahn School of Medicine at Mount Sinai
John M. Dye
John M. Dye United States Army Medical Research Institute of Infectious Diseases
Patrick L. Iversen
Patrick L. Iversen Oregon State University
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Elke Mühlberger
Elke Mühlberger Boston University
Jonathan S. Towner
Jonathan S. Towner Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various nursing and healthcare specialties, many of which offer flexible online education options. For those interested in psychiatric aspects of immune response, exploring the cheapest online pmhnp certificate programs provides an affordable pathway to specialize in psychiatric-mental health nursing.

Advancing your nursing career with a Doctor of Nursing Practice (DNP) degree can open doors to higher salaries and leadership roles. Understanding the highest paid dnp specialties can help guide your choice towards specialties that combine immunology with advanced clinical practice.

Nurses looking to deepen their expertise might consider transitioning between specializations. Those with Family Nurse Practitioner (FNP) credentials can explore programs on how to transition effectively, such as the guide on fnp to acute care np, which is especially valuable for acute immunological conditions.

For accelerated training options, many students benefit from accelerated nurse practitioner programs, helping them swiftly gain the knowledge and credentials needed to work at the forefront of immunology-related healthcare.

Best Scientists Citing Sina Bavari

Trending Scientists

Recently Published Articles